Rubén Niesvizky
Cornell University(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology, Peptidase Inhibition and Analysis, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma(2014)1,316 cited
- → Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America(2007)1,235 cited
- → Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma(2007)835 cited
- → A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma(2004)740 cited
- → Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results(2023)511 cited
- → International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma(2009)481 cited
- → The management of unicentric and multicentric Castleman's disease(1999)413 cited
- → Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group(2010)407 cited
- → Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial(2017)401 cited
- → International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation(2014)381 cited